Europe Biosurgery Market (2019-2025)
The Europe Biosurgery Market would witness market growth of 6% CAGR during the forecast period (2019-2025).
Biosurgery technology has established a new paradigm in wound and tissue management, surgical care, and regenerative healing. Several products under biosurgery have brought in extensive interest among surgeons and patients. This is projected to gain traction in several medical specialties such as gynecology, orthopedic, neurosurgery cardiovascular, and spine-related therapies. The increased need for novel biomaterials for the intra-operative wound as well as tissue management can also be a key trend in improving the biosurgery market. Life sciences companies launch products for surgical care that are highly focused on discovering new avenues in biosurgery by getting involved in relentless development activities.
The European Bio Surgery market's main driver is the strong focus on scientific growth, which in turn leads to the launch of various new products and other technological advances in the area. Along with the growing number of surgeries due to evolving lifestyles and increasing consumer awareness, it will serve as market growth boosters. The main critical factor on the Bio Surgery market in Europe is the inability to accept some products, like human tissue, which is necessary for regenerative purposes due to ethical concerns in some parts of the region. This, along with the high costs and the strict regulations of the government, serves as market restrictions.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
Biosurgery technology has established a new paradigm in wound and tissue management, surgical care, and regenerative healing. Several products under biosurgery have brought in extensive interest among surgeons and patients. This is projected to gain traction in several medical specialties such as gynecology, orthopedic, neurosurgery cardiovascular, and spine-related therapies. The increased need for novel biomaterials for the intra-operative wound as well as tissue management can also be a key trend in improving the biosurgery market. Life sciences companies launch products for surgical care that are highly focused on discovering new avenues in biosurgery by getting involved in relentless development activities.
The European Bio Surgery market's main driver is the strong focus on scientific growth, which in turn leads to the launch of various new products and other technological advances in the area. Along with the growing number of surgeries due to evolving lifestyles and increasing consumer awareness, it will serve as market growth boosters. The main critical factor on the Bio Surgery market in Europe is the inability to accept some products, like human tissue, which is necessary for regenerative purposes due to ethical concerns in some parts of the region. This, along with the high costs and the strict regulations of the government, serves as market restrictions.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
- General Surgeries
- Orthopedic Surgeries
- Neurological Surgeries
- Cardiovascular Surgeries
- Other Applications
- Surgical Sealants
- Soft Tissue Attachments
- Adhesion Barriers
- Hemostatic Agents
- Bone Graft Substitutes
- Other Products
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Baxter International, Inc.
- Johnson and Johnson
- Medtronic PLC
- Pfizer, Inc.
- Stryker Corporation
- B. Braun Melsungen AG
- Sanofi S.A.
- Becton, Dickinson and Company
- Integra LifeSciences Holdings Corporation
- CSL Limited
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Biosurgery Market, by Application
1.4.2 Europe Biosurgery Market, by Product
1.4.3 Europe Biosurgery Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Dec – 2016-Apr) Leading Players
CHAPTER 4. EUROPE BIOSURGERY MARKET BY APPLICATION
4.1 Europe General Surgeries Market by Country
4.2 Europe Orthopedic Surgeries Market by Country
4.3 Europe Neurological Surgeries Market by Country
4.4 Europe Cardiovascular Surgeries Market by Country
4.5 Europe Other Application Biosurgery Market by Country
CHAPTER 5. EUROPE BIOSURGERY MARKET BY PRODUCT
5.1 Europe Surgical sealants Biosurgery Market by Country
5.2 Europe Soft Tissue Attachments Biosurgery Market by Country
5.3 Europe Adhesion Barriers Biosurgery Market by Country
5.4 Europe Hemostatic Agents Biosurgery Market by Country
5.5 Europe Bone Graft Substitutes Biosurgery Market by Country
5.6 Europe Others Biosurgery Market by Country
CHAPTER 6. EUROPE BIOSURGERY MARKET BY COUNTRY
6.1 Germany Biosurgery Market
6.1.1 Germany Biosurgery Market by Application
6.1.2 Germany Biosurgery Market by Product
6.2 UK Biosurgery Market
6.2.1 UK Biosurgery Market by Application
6.2.2 UK Biosurgery Market by Product
6.3 France Biosurgery Market
6.3.1 France Biosurgery Market by Application
6.3.2 France Biosurgery Market by Product
6.4 Russia Biosurgery Market
6.4.1 Russia Biosurgery Market by Application
6.4.2 Russia Biosurgery Market by Product
6.5 Spain Biosurgery Market
6.5.1 Spain Biosurgery Market by Application
6.5.2 Spain Biosurgery Market by Product
6.6 Italy Biosurgery Market
6.6.1 Italy Biosurgery Market by Application
6.6.2 Italy Biosurgery Market by Product
6.7 Rest of Europe Biosurgery Market
6.7.1 Rest of Europe Biosurgery Market by Application
6.7.2 Rest of Europe Biosurgery Market by Product
CHAPTER 7. COMPANY PROFILES
7.1 Baxter International, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Geographical Expansions:
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 CSL Limited
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Biosurgery Market, by Application
1.4.2 Europe Biosurgery Market, by Product
1.4.3 Europe Biosurgery Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Dec – 2016-Apr) Leading Players
CHAPTER 4. EUROPE BIOSURGERY MARKET BY APPLICATION
4.1 Europe General Surgeries Market by Country
4.2 Europe Orthopedic Surgeries Market by Country
4.3 Europe Neurological Surgeries Market by Country
4.4 Europe Cardiovascular Surgeries Market by Country
4.5 Europe Other Application Biosurgery Market by Country
CHAPTER 5. EUROPE BIOSURGERY MARKET BY PRODUCT
5.1 Europe Surgical sealants Biosurgery Market by Country
5.2 Europe Soft Tissue Attachments Biosurgery Market by Country
5.3 Europe Adhesion Barriers Biosurgery Market by Country
5.4 Europe Hemostatic Agents Biosurgery Market by Country
5.5 Europe Bone Graft Substitutes Biosurgery Market by Country
5.6 Europe Others Biosurgery Market by Country
CHAPTER 6. EUROPE BIOSURGERY MARKET BY COUNTRY
6.1 Germany Biosurgery Market
6.1.1 Germany Biosurgery Market by Application
6.1.2 Germany Biosurgery Market by Product
6.2 UK Biosurgery Market
6.2.1 UK Biosurgery Market by Application
6.2.2 UK Biosurgery Market by Product
6.3 France Biosurgery Market
6.3.1 France Biosurgery Market by Application
6.3.2 France Biosurgery Market by Product
6.4 Russia Biosurgery Market
6.4.1 Russia Biosurgery Market by Application
6.4.2 Russia Biosurgery Market by Product
6.5 Spain Biosurgery Market
6.5.1 Spain Biosurgery Market by Application
6.5.2 Spain Biosurgery Market by Product
6.6 Italy Biosurgery Market
6.6.1 Italy Biosurgery Market by Application
6.6.2 Italy Biosurgery Market by Product
6.7 Rest of Europe Biosurgery Market
6.7.1 Rest of Europe Biosurgery Market by Application
6.7.2 Rest of Europe Biosurgery Market by Product
CHAPTER 7. COMPANY PROFILES
7.1 Baxter International, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Geographical Expansions:
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 CSL Limited
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
LIST OF TABLES
TABLE 1 EUROPE BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– BIOSURGERY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– BIOSURGERY MARKET
TABLE 5 GEOGRAPHICAL EXPANSIONS– BIOSURGERY MARKET
TABLE 6 MERGERS & ACQUISITIONS – BIOSURGERY MARKET
TABLE 7 EUROPE BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 EUROPE BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 EUROPE GENERAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE GENERAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 EUROPE CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 EUROPE OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 EUROPE OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 EUROPE BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 20 EUROPE BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 21 EUROPE SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 EUROPE SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 EUROPE ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 EUROPE ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 EUROPE HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 EUROPE OTHERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE OTHERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 GERMANY BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 36 GERMANY BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 37 GERMANY BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 GERMANY BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 GERMANY BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 40 GERMANY BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 41 UK BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 42 UK BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 43 UK BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 UK BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 UK BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 46 UK BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 47 FRANCE BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 48 FRANCE BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 49 FRANCE BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 FRANCE BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 FRANCE BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 52 FRANCE BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 53 RUSSIA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 54 RUSSIA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 55 RUSSIA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 RUSSIA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 RUSSIA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 58 RUSSIA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 59 SPAIN BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 60 SPAIN BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 61 SPAIN BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 SPAIN BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 SPAIN BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 64 SPAIN BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 65 ITALY BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 66 ITALY BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 67 ITALY BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 68 ITALY BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 69 ITALY BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 70 ITALY BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 71 REST OF EUROPE BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 72 REST OF EUROPE BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 73 REST OF EUROPE BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 74 REST OF EUROPE BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 75 REST OF EUROPE BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 76 REST OF EUROPE BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 77 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 78 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 79 KEY INFORMATION – MEDTRONIC PLC
TABLE 80 KEY INFORMATION – PFIZER, INC.
TABLE 81 KEY INFORMATION – STRYKER CORPORATION
TABLE 82 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 83 KEY INFORMATION – SANOFI S.A.
TABLE 84 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 85 KEY INFORMATION – INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 86 KEY INFORMATION – CSL LIMITED
TABLE 1 EUROPE BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– BIOSURGERY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– BIOSURGERY MARKET
TABLE 5 GEOGRAPHICAL EXPANSIONS– BIOSURGERY MARKET
TABLE 6 MERGERS & ACQUISITIONS – BIOSURGERY MARKET
TABLE 7 EUROPE BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 EUROPE BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 EUROPE GENERAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE GENERAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 EUROPE CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 EUROPE OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 EUROPE OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 EUROPE BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 20 EUROPE BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 21 EUROPE SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 EUROPE SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 EUROPE ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 EUROPE ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 EUROPE HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 EUROPE OTHERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE OTHERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 GERMANY BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 36 GERMANY BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 37 GERMANY BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 GERMANY BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 GERMANY BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 40 GERMANY BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 41 UK BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 42 UK BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 43 UK BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 UK BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 UK BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 46 UK BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 47 FRANCE BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 48 FRANCE BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 49 FRANCE BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 FRANCE BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 FRANCE BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 52 FRANCE BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 53 RUSSIA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 54 RUSSIA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 55 RUSSIA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 RUSSIA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 RUSSIA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 58 RUSSIA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 59 SPAIN BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 60 SPAIN BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 61 SPAIN BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 SPAIN BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 SPAIN BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 64 SPAIN BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 65 ITALY BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 66 ITALY BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 67 ITALY BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 68 ITALY BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 69 ITALY BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 70 ITALY BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 71 REST OF EUROPE BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 72 REST OF EUROPE BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 73 REST OF EUROPE BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 74 REST OF EUROPE BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 75 REST OF EUROPE BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 76 REST OF EUROPE BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 77 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 78 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 79 KEY INFORMATION – MEDTRONIC PLC
TABLE 80 KEY INFORMATION – PFIZER, INC.
TABLE 81 KEY INFORMATION – STRYKER CORPORATION
TABLE 82 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 83 KEY INFORMATION – SANOFI S.A.
TABLE 84 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 85 KEY INFORMATION – INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 86 KEY INFORMATION – CSL LIMITED
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-DEC – 2016-APR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BAXTER INTERNATIONAL, INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-DEC – 2016-APR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BAXTER INTERNATIONAL, INC.
